BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Miccheli A, Capuani G, Marini F, Tomassini A, Praticò G, Ceccarelli S, Gnani D, Baviera G, Alisi A, Putignani L, Nobili V. Urinary (1)H-NMR-based metabolic profiling of children with NAFLD undergoing VSL#3 treatment. Int J Obes (Lond) 2015;39:1118-25. [PMID: 25809828 DOI: 10.1038/ijo.2015.40] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Wagner-Skacel J, Dalkner N, Moerkl S, Kreuzer K, Farzi A, Lackner S, Painold A, Reininghaus EZ, Butler MI, Bengesser S. Sleep and Microbiome in Psychiatric Diseases. Nutrients 2020;12:E2198. [PMID: 32718072 DOI: 10.3390/nu12082198] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
2 Xiao MW, Lin SX, Shen ZH, Luo WW, Wang XY. Systematic Review with Meta-Analysis: The Effects of Probiotics in Nonalcoholic Fatty Liver Disease. Gastroenterol Res Pract 2019;2019:1484598. [PMID: 31885541 DOI: 10.1155/2019/1484598] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
3 Troisi J, Pierri L, Landolfi A, Marciano F, Bisogno A, Belmonte F, Palladino C, Guercio Nuzio S, Campiglia P, Vajro P. Urinary Metabolomics in Pediatric Obesity and NAFLD Identifies Metabolic Pathways/Metabolites Related to Dietary Habits and Gut-Liver Axis Perturbations. Nutrients 2017;9:E485. [PMID: 28492501 DOI: 10.3390/nu9050485] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 5.6] [Reference Citation Analysis]
4 Behrouz V, Aryaeian N, Zahedi MJ, Jazayeri S. Effects of probiotic and prebiotic supplementation on metabolic parameters, liver aminotransferases, and systemic inflammation in nonalcoholic fatty liver disease: A randomized clinical trial.J Food Sci. 2020;85:3611-3617. [PMID: 32885440 DOI: 10.1111/1750-3841.15367] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
5 Troisi J, Belmonte F, Bisogno A, Pierri L, Colucci A, Scala G, Cavallo P, Mandato C, Di Nuzzi A, Di Michele L, Delli Bovi AP, Guercio Nuzio S, Vajro P. Metabolomic Salivary Signature of Pediatric Obesity Related Liver Disease and Metabolic Syndrome. Nutrients 2019;11:E274. [PMID: 30691143 DOI: 10.3390/nu11020274] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
6 Plaza-Diaz J, Ruiz-Ojeda FJ, Gil-Campos M, Gil A. Mechanisms of Action of Probiotics.Adv Nutr. 2019;10:S49-S66. [PMID: 30721959 DOI: 10.1093/advances/nmy063] [Cited by in Crossref: 169] [Cited by in F6Publishing: 135] [Article Influence: 84.5] [Reference Citation Analysis]
7 Mielko KA, Pudełko-malik N, Tarczewska A, Młynarz P. NMR spectroscopy as a “green analytical method” in metabolomics and proteomics studies. Sustainable Chemistry and Pharmacy 2021;22:100474. [DOI: 10.1016/j.scp.2021.100474] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Varsha KK, Maheshwari AP, Nampoothiri KM. Accomplishment of probiotics in human health pertaining to immunoregulation and disease control. Clin Nutr ESPEN 2021;44:26-37. [PMID: 34330476 DOI: 10.1016/j.clnesp.2021.06.020] [Reference Citation Analysis]
9 Jayakumar S, Loomba R. Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implications. Aliment Pharmacol Ther 2019;50:144-58. [PMID: 31149745 DOI: 10.1111/apt.15314] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
10 Loman BR, Hernández-Saavedra D, An R, Rector RS. Prebiotic and probiotic treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis. Nutr Rev 2018;76:822-39. [PMID: 30113661 DOI: 10.1093/nutrit/nuy031] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 12.7] [Reference Citation Analysis]
11 Yan B, Huang J, Zhang C, Hu X, Gao M, Shi A, Zha W, Shi L, Huang C, Yang L. Serum metabolomic profiling in patients with systemic lupus erythematosus by GC/MS. Modern Rheumatology 2016;26:914-22. [DOI: 10.3109/14397595.2016.1158895] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 6.2] [Reference Citation Analysis]
12 Jin H, Xu X, Pang B, Yang R, Sun H, Jiang C, Shao D, Shi J. Probiotic and prebiotic interventions for non-alcoholic fatty liver disease: a systematic review and network meta-analysis. Benef Microbes 2021;:1-14. [PMID: 34511051 DOI: 10.3920/BM2020.0183] [Reference Citation Analysis]
13 Maitre L, Lau CE, Vizcaino E, Robinson O, Casas M, Siskos AP, Want EJ, Athersuch T, Slama R, Vrijheid M, Keun HC, Coen M. Assessment of metabolic phenotypic variability in children's urine using 1H NMR spectroscopy. Sci Rep 2017;7:46082. [PMID: 28422130 DOI: 10.1038/srep46082] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
14 Martinez KB, Leone V, Chang EB. Microbial metabolites in health and disease: Navigating the unknown in search of function. J Biol Chem. 2017;292:8553-8559. [PMID: 28389566 DOI: 10.1074/jbc.r116.752899] [Cited by in Crossref: 59] [Cited by in F6Publishing: 35] [Article Influence: 11.8] [Reference Citation Analysis]
15 Chung HJ, Sim JH, Min TS, Choi HK. Metabolomics and Lipidomics Approaches in the Science of Probiotics: A Review. J Med Food 2018;21:1086-95. [PMID: 30004273 DOI: 10.1089/jmf.2017.4175] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
16 Cheng FS, Pan D, Chang B, Jiang M, Sang LX. Probiotic mixture VSL#3: An overview of basic and clinical studies in chronic diseases. World J Clin Cases 2020; 8(8): 1361-1384 [PMID: 32368530 DOI: 10.12998/wjcc.v8.i8.1361] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
17 Wiciński M, Gębalski J, Gołębiewski J, Malinowski B. Probiotics for the Treatment of Overweight and Obesity in Humans-A Review of Clinical Trials. Microorganisms 2020;8:E1148. [PMID: 32751306 DOI: 10.3390/microorganisms8081148] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
18 Tang Y, Huang J, Zhang WY, Qin S, Yang YX, Ren H, Yang QB, Hu H. Effects of probiotics on nonalcoholic fatty liver disease: a systematic review and meta-analysis. Therap Adv Gastroenterol 2019;12:1756284819878046. [PMID: 31598135 DOI: 10.1177/1756284819878046] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
19 Xie C, Halegoua-DeMarzio D. Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter? Nutrients. 2019;11. [PMID: 31752378 DOI: 10.3390/nu11112837] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
20 Tsoukalas D, Alegakis A, Fragkiadaki P, Papakonstantinou E, Nikitovic D, Karataraki A, Nosyrev AE, Papadakis EG, Spandidos DA, Drakoulis N, Tsatsakis AM. Application of metabolomics: Focus on the quantification of organic acids in healthy adults. Int J Mol Med 2017;40:112-20. [PMID: 28498405 DOI: 10.3892/ijmm.2017.2983] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
21 Uji M, Yokoyama Y, Ohbuchi K, Tsuchiya K, Sadakane C, Shimobori C, Yamamoto M, Nagino M. Exploration of serum biomarkers for predicting the response to Inchinkoto (ICKT), a Japanese traditional herbal medicine. Metabolomics 2017;13:155. [PMID: 31375927 DOI: 10.1007/s11306-017-1292-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
22 Biliotti E, Giampaoli O, Sciubba F, Marini F, Tomassini A, Palazzo D, Capuani G, Esvan R, Spaziante M, Taliani G, Miccheli A. Urinary metabolomics of HCV patients with severe liver fibrosis before and during the sustained virologic response achieved by direct acting antiviral treatment. Biomed Pharmacother 2021;143:112217. [PMID: 34560544 DOI: 10.1016/j.biopha.2021.112217] [Reference Citation Analysis]
23 Ristori MV, Mortera SL, Marzano V, Guerrera S, Vernocchi P, Ianiro G, Gardini S, Torre G, Valeri G, Vicari S, Gasbarrini A, Putignani L. Proteomics and Metabolomics Approaches towards a Functional Insight onto AUTISM Spectrum Disorders: Phenotype Stratification and Biomarker Discovery. Int J Mol Sci 2020;21:E6274. [PMID: 32872562 DOI: 10.3390/ijms21176274] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
24 Li P, Zhang T, Xiao Y, Tian L, Cui B, Ji G, Liu YY, Zhang F. Timing for the second fecal microbiota transplantation to maintain the long-term benefit from the first treatment for Crohn's disease. Appl Microbiol Biotechnol. 2019;103:349-360. [PMID: 30357440 DOI: 10.1007/s00253-018-9447-x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 9.0] [Reference Citation Analysis]
25 Grisi M, Conley GM, Rodriguez KJ, Riva E, Egli L, Moritz W, Lichtenberg J, Brugger J, Boero G. NMR microsystem for label-free characterization of 3D nanoliter microtissues. Sci Rep 2020;10:18306. [PMID: 33110145 DOI: 10.1038/s41598-020-75480-0] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Dai X, Hou H, Zhang W, Liu T, Li Y, Wang S, Wang B, Cao H. Microbial Metabolites: Critical Regulators in NAFLD.Front Microbiol. 2020;11:567654. [PMID: 33117316 DOI: 10.3389/fmicb.2020.567654] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
27 Hernandez-Baixauli J, Quesada-Vázquez S, Mariné-Casadó R, Gil Cardoso K, Caimari A, Del Bas JM, Escoté X, Baselga-Escudero L. Detection of Early Disease Risk Factors Associated with Metabolic Syndrome: A New Era with the NMR Metabolomics Assessment. Nutrients 2020;12:E806. [PMID: 32197513 DOI: 10.3390/nu12030806] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
28 Silva RA, Pereira TC, Souza AR, Ribeiro PR. 1H NMR-based metabolite profiling for biomarker identification. Clinica Chimica Acta 2020;502:269-79. [DOI: 10.1016/j.cca.2019.11.015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
29 Yang YJ, Ni YH. Gut microbiota and pediatric obesity/non-alcoholic fatty liver disease. J Formos Med Assoc 2019;118 Suppl 1:S55-61. [PMID: 30509561 DOI: 10.1016/j.jfma.2018.11.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
30 Calcaterra V, Verduci E, Cena H, Magenes VC, Todisco CF, Tenuta E, Gregorio C, De Giuseppe R, Bosetti A, Di Profio E, Zuccotti G. Polycystic Ovary Syndrome in Insulin-Resistant Adolescents with Obesity: The Role of Nutrition Therapy and Food Supplements as a Strategy to Protect Fertility. Nutrients 2021;13:1848. [PMID: 34071499 DOI: 10.3390/nu13061848] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
31 Gómez-Cebrián N, Vázquez Ferreiro P, Carrera Hueso FJ, Poveda Andrés JL, Puchades-Carrasco L, Pineda-Lucena A. Pharmacometabolomics by NMR in Oncology: A Systematic Review. Pharmaceuticals (Basel) 2021;14:1015. [PMID: 34681239 DOI: 10.3390/ph14101015] [Reference Citation Analysis]
32 Tursi A, Mastromarino P, Capobianco D, Elisei W, Miccheli A, Pratico' G, Picchio M, Brandimarte G. Urinary metabolic profiling and symptomatic uncomplicated diverticular disease of the colon. Clin Res Hepatol Gastroenterol 2017;41:344-6. [PMID: 28286055 DOI: 10.1016/j.clinre.2017.01.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
33 Rodríguez A, Becerril S, Ezquerro S, Méndez-giménez L, Frühbeck G. Crosstalk between adipokines and myokines in fat browning. Acta Physiol 2017;219:362-81. [DOI: 10.1111/apha.12686] [Cited by in Crossref: 98] [Cited by in F6Publishing: 87] [Article Influence: 16.3] [Reference Citation Analysis]
34 Du S, Sun S, Liu L, Zhang Q, Guo F, Li C, Feng R, Sun C. Effects of Histidine Supplementation on Global Serum and Urine 1 H NMR-based Metabolomics and Serum Amino Acid Profiles in Obese Women from a Randomized Controlled Study. J Proteome Res 2017;16:2221-30. [DOI: 10.1021/acs.jproteome.7b00030] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]